People Search
Phones, Emails, Addresses, Background check, Web references
All public info
Like other search engines (Google or Bing) Radaris collects information from public sources.
Noriyuki NAKASHIMA (Application Technology, Novozymes Japan Ltd.) 11:20~11:55: S-4 "Fungi as a Rich Source of New Drugs - Development of Micafungin"
KOHMURA Takahide, HASEGAWA Yasuhisa, OGAWA Tetsuya, TAKAHASHI Masakatsu, YANAGITA Noriyuki, NAKASHIMA Tsutomu Immunohistochemical study of p53, Cyclin D1 in multiple primary ...
... of Advanced Industrial Science and Technology, Aomi Koto-ku, Tokyo, Japan) A4P9 Tryptophan scanning mutagenesis in the S1 domain of HCN channel Takahiro Ishii, Noriyuki Nakashima and ...
Akio NOHARA*,Yusuke UCHIYAMA**,Noriyuki NAKASHIMA** *Reseach and Development Center, Nippon Koei Co.,Ltd. **River and Hydraulic Engineering Dept., Nippon Koei Co.,Ltd.
[title in Japanese] 83: makoto ishikawa, naoki okamoto, noriyuki nakashima and *jumpei nakatsuka ...
KOHMURA Takahide, HASEGAWA Yasuhisa, OGAWA Tetsuya, TAKAHASHI Masakatsu, YANAGITA Noriyuki, NAKASHIMA Tsutomu Immunohistochemical study of p53, Cyclin D1 in multiple ...
Noriyuki NAKASHIMA (Application Technology, Novozymes Japan Ltd.) 11:20~11:55: S-4 "Fungi as a Rich Source of New Drugs - Development of Micafungin"
... Industrial Science and Technology, Aomi Koto-ku, Tokyo, Japan) A4P9 Tryptophan scanning mutagenesis in the S1 domain of HCN channel Takahiro Ishii, Noriyuki Nakashima and ...
Linkedin